| Dr Saba Halim Khalid, MD | |
|
5400 W Hillsdale Ave, Visalia, CA 93291-8222 | |
| (595) 738-7505 | |
| (559) 738-7560 |
| Full Name | Dr Saba Halim Khalid |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 5400 W Hillsdale Ave, Visalia, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083666531 | NPI | - | NPPES |
| 364455500 | Other | IL | TAX ID |
| 036088841 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 036088841 (Illinois) | Secondary |
| 208000000X | Pediatrics | A70535 (California) | Primary |
| Entity Name | Adventist Health Physicians Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063718583 PECOS PAC ID: 3274580972 Enrollment ID: O20050407000633 |
News Archive
Overweight American children and adolescents have become fatter over the last decade, according to researchers at the Johns Hopkins Bloomberg School of Public Health and National Institute on Aging (NIA). They examined adiposity shifts across socio-demographic groups over time and found U.S. children and adolescents had significantly increased adiposity measures such as body mass index (BMI), waist circumference (WC) and triceps skinfold thickness (TST).
Abbott today announced it has received U.S. Food and Drug Administration approval for the XIENCE nano Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease in small vessels.
Sequella, Inc., a clinical-stage biopharmaceutical company focused on diseases of epidemic potential, announced today that SQ109, its lead drug candidate for the treatment of tuberculosis (TB), was the first drug approved for evaluation in a newly awarded clinical program contract to Dynport Vaccine Company LLC and Quintiles Transnational.
Novalar Pharmaceuticals, Inc. today announced the submission of a New Drug Application (NDA) to the U. S. Food and Drug Administration (FDA) for marketing approval of NV-101, a local dental anesthetic reversal agent.
When researchers at Moffitt Cancer Center and colleagues conducted a random telephone survey among blacks, whites and Hispanics in New York, Baltimore and San Juan, Puerto Rico, they found that Hispanics are nearly twice as likely to report that fear of being used as a "guinea pig" and lack of trust in medical professionals contribute in being unwilling to participate in cancer screenings.
› Verified 1 days ago
| Entity Name | Kaweah Delta Health Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619353042 PECOS PAC ID: 4082923818 Enrollment ID: O20151019001526 |
News Archive
Overweight American children and adolescents have become fatter over the last decade, according to researchers at the Johns Hopkins Bloomberg School of Public Health and National Institute on Aging (NIA). They examined adiposity shifts across socio-demographic groups over time and found U.S. children and adolescents had significantly increased adiposity measures such as body mass index (BMI), waist circumference (WC) and triceps skinfold thickness (TST).
Abbott today announced it has received U.S. Food and Drug Administration approval for the XIENCE nano Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease in small vessels.
Sequella, Inc., a clinical-stage biopharmaceutical company focused on diseases of epidemic potential, announced today that SQ109, its lead drug candidate for the treatment of tuberculosis (TB), was the first drug approved for evaluation in a newly awarded clinical program contract to Dynport Vaccine Company LLC and Quintiles Transnational.
Novalar Pharmaceuticals, Inc. today announced the submission of a New Drug Application (NDA) to the U. S. Food and Drug Administration (FDA) for marketing approval of NV-101, a local dental anesthetic reversal agent.
When researchers at Moffitt Cancer Center and colleagues conducted a random telephone survey among blacks, whites and Hispanics in New York, Baltimore and San Juan, Puerto Rico, they found that Hispanics are nearly twice as likely to report that fear of being used as a "guinea pig" and lack of trust in medical professionals contribute in being unwilling to participate in cancer screenings.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Saba Halim Khalid, MD 5400 W Hillsdale Ave, Visalia, CA 93291-8222 Ph: (595) 738-7505 | Dr Saba Halim Khalid, MD 5400 W Hillsdale Ave, Visalia, CA 93291-8222 Ph: (595) 738-7505 |
News Archive
Overweight American children and adolescents have become fatter over the last decade, according to researchers at the Johns Hopkins Bloomberg School of Public Health and National Institute on Aging (NIA). They examined adiposity shifts across socio-demographic groups over time and found U.S. children and adolescents had significantly increased adiposity measures such as body mass index (BMI), waist circumference (WC) and triceps skinfold thickness (TST).
Abbott today announced it has received U.S. Food and Drug Administration approval for the XIENCE nano Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease in small vessels.
Sequella, Inc., a clinical-stage biopharmaceutical company focused on diseases of epidemic potential, announced today that SQ109, its lead drug candidate for the treatment of tuberculosis (TB), was the first drug approved for evaluation in a newly awarded clinical program contract to Dynport Vaccine Company LLC and Quintiles Transnational.
Novalar Pharmaceuticals, Inc. today announced the submission of a New Drug Application (NDA) to the U. S. Food and Drug Administration (FDA) for marketing approval of NV-101, a local dental anesthetic reversal agent.
When researchers at Moffitt Cancer Center and colleagues conducted a random telephone survey among blacks, whites and Hispanics in New York, Baltimore and San Juan, Puerto Rico, they found that Hispanics are nearly twice as likely to report that fear of being used as a "guinea pig" and lack of trust in medical professionals contribute in being unwilling to participate in cancer screenings.
› Verified 1 days ago
Dr. Kathryn Hall, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 5400 W Hillsdale Ave, Visalia, CA 93291 Phone: 559-738-7500 Fax: 559-738-7560 | |
Lance Toshio Tomooka, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 5400 W Hillsdale Ave, Visalia, CA 93291 Phone: 559-738-7500 Fax: 559-738-7560 | |
Dr. Rupa Varma, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 501 North Bridge Street, Visalia, CA 93291 Phone: 559-734-1939 Fax: 559-734-4384 | |
Dr. Wilson S Chen, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 501 N Bridge St, Visalia, CA 93291 Phone: 559-734-1939 Fax: 559-734-4384 | |
Dr. Catherine A Mcninch, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 5400 W Hillsdale Ave, Visalia, CA 93291 Phone: 559-738-7500 Fax: 559-738-7650 | |
Kelsey Raeann Leyendekker, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8150 Avenue 360, Visalia, CA 93291 Phone: 559-786-3104 |